Payments to Acquire Property, Plant, and Equipment of NAVIDEA BIOPHARMACEUTICALS, INC. from 31 Dec 2010 to 31 Mar 2023

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
NAVIDEA BIOPHARMACEUTICALS, INC. quarterly and annual Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2010 to 31 Mar 2023.
  • NAVIDEA BIOPHARMACEUTICALS, INC. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2023 was $15,068, a 64% decline year-over-year.
  • NAVIDEA BIOPHARMACEUTICALS, INC. Payments to Acquire Property, Plant, and Equipment for the twelve months ending 31 Mar 2023 was $36,137, a 46% decline year-over-year.
  • NAVIDEA BIOPHARMACEUTICALS, INC. annual Payments to Acquire Property, Plant, and Equipment for 2022 was $63,086, a 150% increase from 2021.
  • NAVIDEA BIOPHARMACEUTICALS, INC. annual Payments to Acquire Property, Plant, and Equipment for 2021 was $25,218, a 81% decline from 2020.
  • NAVIDEA BIOPHARMACEUTICALS, INC. annual Payments to Acquire Property, Plant, and Equipment for 2020 was $135,881, a 10701% increase from 2019.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Trailing 12 Months (USD)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)

NAVIDEA BIOPHARMACEUTICALS, INC. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2023 $36,137 $15,068 -$26,949 -64% 01 Jan 2023 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $63,086 $42,017 -$46,486 -1040% 01 Oct 2022 31 Dec 2022 10-K 27 Mar 2023 2022 FY
Q3 2022 $109,572 $14,429 -$3,613 -20% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 $113,185 $48,657 +$45,950 +1697% 01 Apr 2022 30 Jun 2022 10-Q 11 Aug 2023 2023 Q2
Q1 2022 $67,235 $42,017 +$42,017 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $25,218 $4,469 -$2,196 -33% 01 Oct 2021 31 Dec 2021 10-K 27 Mar 2023 2022 FY
Q3 2021 $27,414 $18,042 -$102,768 -85% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $130,182 $2,707 +$760 +39% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022 2022 Q2
Q1 2021 $129,422 $0 -$6,459 -100% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1
Q4 2020 $135,881 $6,665 01 Oct 2020 31 Dec 2020 10-K 28 Mar 2022 2021 FY
Q3 2020 $120,810 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021 2021 Q3
Q2 2020 $1,947 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 $6,459 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q3 2018 $16,152 -$7,095 -31% 01 Jul 2018 30 Sep 2018 10-Q 08 Nov 2019 2019 Q3
Q2 2018 $3,165 -$5,005 -61% 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2019 2019 Q2
Q4 2017 $33,690 $2,273 +$5,967 01 Oct 2017 31 Dec 2017 10-K 15 Mar 2019 2018 FY
Q3 2017 $27,723 $23,247 +$21,400 +1159% 01 Jul 2017 30 Sep 2017 10-Q 09 Nov 2018 2018 Q3
Q2 2017 $6,323 $8,170 +$6,323 +342% 01 Apr 2017 30 Jun 2017 10-Q 08 Aug 2018 2018 Q2
Q1 2017 $0 $0 -$1,847 -100% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 $1,847 $3,694 -$12,289 -143% 01 Oct 2016 31 Dec 2016 10-K 15 Mar 2018 2017 FY
Q3 2016 $14,136 $1,847 -$941 -34% 01 Jul 2016 30 Sep 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 $15,077 $1,847 -$25,771 -93% 01 Apr 2016 30 Jun 2016 10-Q 09 Aug 2017 2017 Q2
Q1 2016 $40,848 $1,847 +$1,847 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017 2017 Q1
Q4 2015 $39,001 $8,595 01 Oct 2015 31 Dec 2015 10-K 15 Mar 2018 2017 FY
Q3 2015 $2,788 01 Jul 2015 30 Sep 2015 10-Q 09 Nov 2016 2016 Q3
Q2 2015 $27,618 01 Apr 2015 30 Jun 2015 10-Q 11 Aug 2016 2016 Q2
Q1 2015 $0 -$985,578 -100% 01 Jan 2015 31 Mar 2015 10-Q 11 May 2015 2015 Q1
Q1 2014 $985,578 +$630,257 +177% 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015 2015 Q1
Q1 2013 $355,321 +$213,894 +151% 01 Jan 2013 31 Mar 2013 10-Q 09 May 2014 2014 Q1
Q1 2012 $141,427 +$84,802 +150% 01 Jan 2012 31 Mar 2012 10-Q 10 May 2013 2013 Q1
Q1 2011 $56,625 01 Jan 2011 31 Mar 2011 10-Q 10 May 2012 2012 Q1

NAVIDEA BIOPHARMACEUTICALS, INC. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 $63,086 +$37,868 +150% 01 Jan 2022 31 Dec 2022 10-K 27 Mar 2023 2022 FY
2021 $25,218 -$110,663 -81% 01 Jan 2021 31 Dec 2021 10-K 27 Mar 2023 2022 FY
2020 $135,881 +$134,623 +10701% 01 Jan 2020 31 Dec 2020 10-K 28 Mar 2022 2021 FY
2019 $1,258 -$44,934 -97% 01 Jan 2019 31 Dec 2019 10-K 26 Mar 2021 2020 FY
2018 $46,192 +$12,502 +37% 01 Jan 2018 31 Dec 2018 10-K 18 Mar 2020 2019 FY
2017 $33,690 +$31,843 +1724% 01 Jan 2017 31 Dec 2017 10-K 15 Mar 2019 2018 FY
2016 $1,847 -$37,154 -95% 01 Jan 2016 31 Dec 2016 10-K 15 Mar 2018 2017 FY
2015 $39,001 -$1,075,447 -96% 01 Jan 2015 31 Dec 2015 10-K 15 Mar 2018 2017 FY
2014 $1,114,448 -$125,218 -10% 01 Jan 2014 31 Dec 2014 8-K 15 Dec 2017 2016 FY
2013 $1,239,666 +$576,318 +87% 01 Jan 2013 31 Dec 2013 10-K 23 Mar 2016 2015 FY
2012 $663,348 +$479,518 +261% 01 Jan 2012 31 Dec 2012 10-K 16 Mar 2015 2014 FY
2011 $183,830 -$182,799 -50% 01 Jan 2011 31 Dec 2011 10-K 14 Mar 2014 2013 FY
2010 $366,629 01 Jan 2010 31 Dec 2010 10-K/A 21 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.